Oligonucleotide and peptide therapeutics is becoming a potent addition to conventional small molecule and biologics drugs to treat diverse diseases, including cancer, metabolic, cardiovascular, neurologic, genetic and other disorders. The TIDES conference is an annual global event aimed at sharing experience, and accelerating oligonucleotide and peptide drug development from discovery through clinical research and commercialization. The upcoming TIDES 2015 will take place in San Diego on May 3–6, where over 1,000 academic, government and industry experts from more than 25 countries will discuss the cutting-edge technologies, strategies and applications for oligonucleotide and peptide therapeutics.
RiboBio is an industry leader in oligonucleotide research and manufacturing in China, and is a committed contributor to global progress in oligo therapeutics development. The company has built a professional and experienced oligonucleotide R&D team and has established a comprehensive cGMP manufacturing facility with advanced equipment.
RiboBio welcomes colleagues, existing and prospect partners, as well as people simply interested in oligonucleotide research and applications, to visit us at the booth #426 during the TIDES 2015 in San Diego.
TIDES official website: http://www.ibclifesciences.com/TIDES/overview.xml
Stella Guan (China)
Phone: (+86) 20-3229022 ext. 656
Dmitry Samarsky (USA)
Phone: (+1) 508-517-7566